United Biomedical Inc., Asia
4 clinical trials · Sponsor
◉ Watch United Biomedical Inc., Asia
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Ability of UB-612 COVID-19 Vaccine to Boost Immunity of Heterologous COVID-19 Vaccines. (NCT05167253) | United Biomedical Inc., Asia | 2022-02-15 |
| A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine (NCT04967742) | United Biomedical Inc., Asia | 2021-08-05 |
| A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers (NCT04773067) | United Biomedical Inc., Asia | 2021-01-30 |
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine (NCT04545749) | United Biomedical Inc., Asia | 2020-09-25 |
Track United Biomedical Inc., Asia automatically
Every clearance here is in the API, with alerts when new ones post.